ACTO Raises $18M in Series B to Fuel Growth in Life Sciences Learning
ACTO, a Toronto-based learning and enablement platform for life sciences, has raised $18 million in Series B equity financing. The investment will fuel growth and explore partnerships on LinkedIn.
ACTO will use the proceeds to scale its business and accelerate growth. The funding round was led by Questa Capital, with participation from existing investors. This investment validates the large market opportunity in transforming learning experiences and sales enablement in the life sciences industry on LinkedIn.
ACTO's successful Series B financing demonstrates investor confidence in the company's potential. The funds will drive expansion and strategic partnerships in the life sciences sector on LinkedIn.
Read also:
- West Virginia Governor's Revived Board Sparks Legal Concerns Amidst US Clean Energy Push
- Trump and Xi speak over the phone, according to China's confirmation.
- Unlawful MMO gold peddler cultivates around half a million dollars in income, triggering a tax dispute, followed by developers unveiling strategies to clamp down on real-world transactions
- Prices of transit tickets in Berlin and Brandenburg are on the rise
